HCW Biologics maintains momentum toward IND application completion
HCW Biologics said it is progressing toward completing its IND application for a clinical study evaluating its lead T-cell engager in solid tumors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
HCW Biologics maintains momentum toward completing IND application
HCW Biologics says it is maintaining momentum toward completion of an IND application for a clinical study to evaluate its lead T-cell engager in solid tumors.